PubRank

Norbert Galldiks

Author PubWeight™ 30.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma. J Nucl Med 2012 3.67
2 Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci U S A 2004 2.54
3 Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J Neurosci 2006 1.46
4 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. J Nucl Med 2005 1.44
5 Differentiation of local tumor recurrence from radiation-induced changes after stereotactic radiosurgery for treatment of brain metastasis: case report and review of the literature. Radiat Oncol 2013 0.97
6 Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes. Hum Gene Ther 2003 0.92
7 Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors. J Nucl Med 2014 0.92
8 Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy. Radiother Oncol 2011 0.92
9 Reply to "[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et al. Neuro Oncol 2013 0.85
10 Sequential escalation of therapy in "malignant" cerebral venous and sinus thrombosis. Neurocrit Care 2010 0.85
11 Posthypoxic myoclonus (Lance-Adams syndrome) treated with lacosamide. Clin Neuropharmacol 2010 0.85
12 The use of O-(2-18F-fluoroethyl)-L-tyrosine PET for treatment management of bevacizumab and irinotecan in patients with recurrent high-grade glioma: a cost-effectiveness analysis. J Nucl Med 2013 0.84
13 Hypermetabolism in 18F-FDG PET predicts favorable outcome following decompressive surgery in patients with degenerative cervical myelopathy. J Nucl Med 2013 0.84
14 Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI. Eur J Nucl Med Mol Imaging 2015 0.83
15 Dual-time-point O-(2-[(18)F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas. Eur Radiol 2015 0.83
16 Letter to the Editor: "The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline" [J Neurooncol 2014; 118:435-460]. J Neurooncol 2014 0.83
17 Clinical value of O-(2-[(18)F]-fluoroethyl)-L-tyrosine positron emission tomography in patients with low-grade glioma. Neurosurg Focus 2013 0.83
18 Ocular flutter, generalized myoclonus, and trunk ataxia associated with anti-GQ1b antibodies. Arch Neurol 2008 0.81
19 The severity of ischemia determines and predicts malignant brain edema in patients with large middle cerebral artery infarction. Cerebrovasc Dis 2011 0.80
20 Uptake and tracer kinetics of O-(2-(18)F-fluoroethyl)-L-tyrosine in meningiomas: preliminary results. Eur J Nucl Med Mol Imaging 2014 0.79
21 Monitoring of radiochemotherapy in patients with glioblastoma using O-(2-¹⁸Fluoroethyl)-L-tyrosine positron emission tomography: is dynamic imaging helpful? Mol Imaging 2013 0.79
22 Early electroencephalography in acute ischemic stroke: prediction of a malignant course? Clin Neurol Neurosurg 2006 0.79
23 Earlier diagnosis of progressive disease during bevacizumab treatment using O-(2-18F-fluorethyl)-L-tyrosine positron emission tomography in comparison with magnetic resonance imaging. Mol Imaging 2013 0.79
24 Prognostic value of 18F-FDG PET in monosegmental stenosis and myelopathy of the cervical spinal cord. J Nucl Med 2011 0.78
25 Stereotactic iodine-125 brachytherapy for the treatment of WHO grades II and III gliomas located in the central sulcus region. Neuro Oncol 2013 0.77
26 Detection of remote neuronal reactions in the Thalamus and Hippocampus induced by rat glioma using the PET tracer cis-4-[¹⁸F]fluoro-D-proline. J Cereb Blood Flow Metab 2013 0.77
27 Isomers of 4-[18F]fluoro-proline: radiosynthesis, biological evaluation and results in humans using PET. Curr Radiopharm 2014 0.77
28 Relationship of regional cerebral blood flow and kinetic behaviour of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake in cerebral gliomas. Nucl Med Commun 2014 0.76
29 Low-dose rate stereotactic iodine-125 brachytherapy for the treatment of inoperable primary and recurrent glioblastoma: single-center experience with 201 cases. J Neurooncol 2014 0.76
30 Sensitivity of intraoperative 5-aminolevulinic acid fluorescence compared with PET using O-(2-¹⁸F-fluoroethyl)-L-tyrosine to detect cerebral gliomas. Neurol Res 2013 0.75
31 A rare differential diagnosis in dysphagia: wound botulism. Laryngoscope 2006 0.75
32 Reply: discriminating ability of (18)F-FET PET for several cerebral neoplastic lesions. J Nucl Med 2013 0.75
33 AIDS-Related Central Nervous System Toxoplasmosis With Increased 18F-Fluoroethyl-L-Tyrosine Amino Acid PET Uptake Due to LAT1/2 Expression of Inflammatory Cells. Clin Nucl Med 2017 0.75
34 Traction lesion of the brachial plexus during bodyflying. J Neurol 2010 0.75
35 Thoracic disc herniation with affection of the anterior spinothalamic tract: a case report and review of literature. Neurol India 2011 0.75
36 Clinical value of 2-deoxy-[18F]fluoro-D-glucose positron emission tomography in patients with cervical spondylotic myelopathy. Neurosurg Focus 2013 0.75